JKMS :: Journal of Korean Medical Science
Frontiers | The Epidemiology and Pathogenesis of Kawasaki Disease
Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks | Italian Journal of Pediatrics | Full Text
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text
The up‐to‐date pathophysiology of Kawasaki disease - Hara - 2021 - Clinical & Translational Immunology - Wiley Online Library
Recurrent Kawasaki Disease-Like Syndrome in a Patient with Acquired Immunodeficiency Syndrome
Rheumato | Free Full-Text | Kawasaki Disease: Management Challenges during COVID-19 Pandemic with an Upsurge in Multisystem Inflammatory Syndrome in Children
Rheumato | Free Full-Text | Kawasaki Disease: Management Challenges during COVID-19 Pandemic with an Upsurge in Multisystem Inflammatory Syndrome in Children
Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial - The Lancet Child & Adolescent Health
![PDF] Recurrent Kawasaki disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/aa3a394f511eb113de41030fcbbefdfba677a432/2-Figure1-1.png "PDF] Recurrent Kawasaki disease. | Semantic Scholar")
PDF] Recurrent Kawasaki disease. | Semantic Scholar
Clinical characteristics of patients with recurrent Kawasaki disease: a nationwide cohort study of 19 456 patients with minimum 3-year follow up | Archives of Disease in Childhood
Recurrent Kawasaki disease | British Dental Journal
Frontiers | How Should We Classify Kawasaki Disease?
Late Treatment and Recurrence of Kawasaki Disease in a Moroccan Infant
Children | Free Full-Text | Major Complication Following Kawasaki Disease in an Infant—The Development of Apical Infarction and Aneurysm Formation
Recurrence of Fever After Initial Intravenous Immunoglobulin Treatment in Children With Kawasaki Disease - Masanori Yoshida, Shinji Oana, Hiroshi Masuda, Akira Ishiguro, Hitoshi Kato, Shuichi Ito, Tohru Kobayashi, Jun Abe, 2018
Searching for the cause of Kawasaki disease — cytoplasmic inclusion bodies provide new insight | Nature Reviews Microbiology
Environmental epidemiology of Kawasaki disease: Linking disease etiology, pathogenesis and global distribution | PLOS ONE
Recurrence of Kawasaki Disease: Look Before you Leap on the Bandwagon Recurrence of Kawasaki Disease: Authors' Reply
Associations between the spatiotemporal distribution of Kawasaki disease and environmental factors: evidence supporting a multifactorial etiologic model | Scientific Reports
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation
The effects of early intravenous immunoglobulin therapy for Kawasaki disease: The 22nd nationwide survey in Japan - ScienceDirect
Recurrent Kawasaki disease and cardiac complications: nationwide surveys in Japan | Archives of Disease in Childhood
A case of recurrent Kawasaki disease | Osteopathic Family Physician
Kawasaki Disease
